{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:45:42Z","timestamp":1790264742940,"version":"4.1.0"},"reference-count":210,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1053\/j.semnuclmed.2006.03.007","type":"journal-article","created":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T13:19:17Z","timestamp":1149772757000},"page":"228-247","source":"Crossref","is-referenced-by-count":331,"title":["Imaging of Neuroendocrine Tumors"],"prefix":"10.1053","volume":"36","author":[{"given":"Vittoria","family":"Rufini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Calcagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2006.03.007_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/er.2003-0014","article-title":"The diagnosis and medical management of advanced neuroendocrine tumors","volume":"25","author":"Kaltsas","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib2","series-title":"Histological typing of endocrine tumors","author":"Solcia","year":"2000"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib3","first-page":"349","article-title":"Radiolabeled adrenergic neuron blocking agents","volume":"21","author":"Wieland","year":"1980","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0001-2998(85)80022-2","article-title":"Radioiodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors","volume":"5","author":"McEwan","year":"1985","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib5","first-page":"207","article-title":"Outcome of [131I]metaiodobenzylguanidine therapy of neuroblastoma","volume":"35","author":"Hor","year":"1991","journal-title":"J Nucl Biol Med"},{"issue":"suppl. 1 to no. 4","key":"10.1053\/j.semnuclmed.2006.03.007_bib6","first-page":"3","article-title":"The current status of Meta-Iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors","volume":"39","author":"Shapiro","year":"1995","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib7","first-page":"679","article-title":"Current concepts on the diagnostic use of MIBG in children","volume":"39","author":"Shulkin","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib8","first-page":"445","article-title":"MIBG therapy","volume":"vol 1","author":"Hoefnagel","year":"2004"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib9","first-page":"83","article-title":"MIBG in diagnosis of neuroendocrine tumors","volume":"vol 1","author":"Troncone","year":"2004"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/snuc.2002.31022","article-title":"Somatostatin receptor imaging","volume":"32","author":"Kwekkeboom","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib11","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1200\/JCO.2004.10.216","article-title":"Receptor imaging in oncology by means of nuclear medicine","volume":"22","author":"Van Den Bossche","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.beem.2004.11.001","article-title":"Developments in PET for the detection of endocrine tumours","volume":"19","author":"Eriksson","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib13","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","article-title":"Biokinetics and imaging with the somatostatin receptor PET radioligand Ga-68 DOTATOC","volume":"28","author":"Hofmann","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00761-004-0716-1","article-title":"Nuklearmedizinische Diagnostik neuroendokriner Tumoren","volume":"10","author":"Baum","year":"2004","journal-title":"Onkologe"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00173043","article-title":"Radioiodinated metaiodobenzylguanidine","volume":"21","author":"Wafelman","year":"1994","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib16","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/sj.bjc.6601276","article-title":"Uptake of meta-iodobenzylguanidine in neuroendocrine tumors is mediated by vesicular monoamine transporters","volume":"89","author":"Kolby","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib17","first-page":"BP132","article-title":"131I\/123I-Metaiodobenzylguanidine (MIBG) scintigraphy","volume":"30","author":"Bombardieri","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s002590000263","article-title":"123I-MIBG scintigraphy of catecholamine systems","volume":"27","author":"Eisenhofer","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0969-8043(93)90179-E","article-title":"No-carrier-added synthesis of meta-[131I]iodobenzylguanidine","volume":"44","author":"Vaidyanathan","year":"1993","journal-title":"Appl Radiat Isot"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib20","first-page":"1088","article-title":"No-carrier-added iodine-131-MIBG. Evaluation of a therapeutic preparation","volume":"36","author":"Mairs","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00006231-200005000-00005","article-title":"No-carrier-added 123I-MIBG","volume":"21","author":"Owens","year":"2000","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib22","first-page":"1464","article-title":"Iodine-123-MIBG imaging of neuroblastoma","volume":"37","author":"Rufini","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/108497804773391775","article-title":"Functional-anatomical image fusion in neuroendocrine tumors","volume":"19","author":"Schillaci","year":"2004","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib24","first-page":"542","article-title":"Conjugate view gammacamera method for estimating tumor uptake of iodine-131 meta-iodobenzylguanidine","volume":"29","author":"Shulkin","year":"1988","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib25","first-page":"803","article-title":"Refining interpretation of MIBG scans in children","volume":"35","author":"Bonnin","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib26","first-page":"1421","article-title":"123I-Metaiodobenzylguanidine uptake in the nape of the neck of children","volume":"44","author":"Okuyama","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00247-003-1136-x","article-title":"123I-MIBG uptake in the neck and shoulders of a neuroblastoma patient","volume":"34","author":"Gelfand","year":"2004","journal-title":"Pediatr Radiol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib28","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJM200005113421915","article-title":"Transient enhanced uptake of 123I- metaiodobenzylguanidine in the contralateral adrenal region after resection of an adrenal pheochromocytoma","volume":"342","author":"Boersma","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib29","first-page":"1352","article-title":"The specificity of radioiodinated MIBG for neural crest tumors in childhood","volume":"38","author":"Leung","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","article-title":"Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use","volume":"27","author":"Reubi","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","article-title":"Concomitant expression of several peptide receptors in neuroendocrine tumours","volume":"30","author":"Reubi","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","article-title":"Peptide receptors as molecular targets for cancer diagnosis and therapy","volume":"24","author":"Reubi","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib33","first-page":"88","article-title":"In situ radiotherapy with 111In-pentetreotide. State of the art and perspectives","volume":"44","author":"McCarthy","year":"2000","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/snuc\/2002.31025","article-title":"Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide","volume":"32","author":"Valkema","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib35","first-page":"BP140","article-title":"111In-pentetreotide scintigraphy","volume":"30","author":"Bombardieri","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib36","first-page":"1144","article-title":"New octreotide derivatives labelled with technetium-99m","volume":"37","author":"Maecke","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib37","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s002590050398","article-title":"Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-DPhe1-Tyr3-octreotide ([86Y]SMT487) using positron emission tomography","volume":"26","author":"R\u00f6sch","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib38","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1021\/jm980602h","article-title":"Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model","volume":"42","author":"Lewis","year":"1999","journal-title":"J Med Chem"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib39","first-page":"762","article-title":"111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients","volume":"40","author":"Kwekkeboom","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib40","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s002590050476","article-title":"Yttrium-90 DOTATOC","volume":"26","author":"Otte","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib41","first-page":"610","article-title":"Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC","volume":"43","author":"Waldherr","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s002590100490","article-title":"Receptor-mediated radiotherapy with 90Y-DOTA-d-Phe1-Tyr3-octreotide","volume":"28","author":"Paganelli","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib43","first-page":"55S","article-title":"MIBG and somatostatin receptor analogs in children","volume":"46","author":"Pashankar","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib44","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1677\/erc.1.01116","article-title":"Treatment of advanced neuroendocrine tumours with radiolabeled somatostatin analogues","volume":"12","author":"Kaltsas","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib45","first-page":"1704","article-title":"Peptide receptor imaging and therapy","volume":"41","author":"Kwekkeboom","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib46","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1078-0432.1136.11.3","article-title":"Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy","volume":"11","author":"Ginj","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib47","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00259-004-1697-4","article-title":"68Ga-DOTANOC","volume":"32","author":"Wild","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib48","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00259-003-1255-5","article-title":"DOTA-NOC, a high-affinity ligand of somatostatin receptors subtypes 2, 3 and 5 for labelling with various radiometals","volume":"30","author":"Wild","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib49","first-page":"S54","article-title":"Receptor PET\/CT imaging of neuroendocrine tumors using the Ga-68 labelled, high affinity somatostatin analogue DOTA-1-Nal3-octreotide (DOTA-NOC)","volume":"32","author":"Baum","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib50","first-page":"50","article-title":"New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy","volume":"44","author":"Virgolini","year":"2000","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib51","first-page":"67S","article-title":"Candidates for peptide receptor radiotherapy today and in the future","volume":"46","author":"Reubi","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib52","first-page":"42","article-title":"Results and potential in neuroendocrine gastro-entero-pancreatic tumors","volume":"44","author":"Chiti","year":"2000","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib53","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1089\/10849780152752119","article-title":"Octreoscan SPET evaluation in the diagnosis of pancreas neuroendocrine tumors","volume":"16","author":"Briganti","year":"2001","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib54","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/annonc\/mdh216","article-title":"Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system","volume":"15","author":"Oberg","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.beem.2004.11.016","article-title":"Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours","volume":"19","author":"Oberg","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/snuc.2002.31020","article-title":"Radiolabeled peptides in diagnosis and tumor imaging","volume":"32","author":"Warner","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib57","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM199410273311703","article-title":"Vasoactive intestinal peptide (VIP) receptor imaging in the localization of intestinal adenocarcinomas and endocrine tumors","volume":"331","author":"Virgolini","year":"1994","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2006.03.007_bib58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000080742","article-title":"Somatostatin and other peptides receptors as tools for tumor diagnosis and treatment","volume":"80","author":"Reubi","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib59","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/(SICI)1097-0215(19991126)83:5<657::AID-IJC15>3.0.CO;2-Y","article-title":"Pre-clinical evaluation of [(111)In-DTPA-Pro(1),Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy","volume":"83","author":"Breeman","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib60","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s002590000355","article-title":"Technetium 99m RP527, a GRP analogue for visualization of GRP receptor-expressing malignancies","volume":"27","author":"Van de Wiele","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib61","first-page":"823","article-title":"Novel series of 111In- labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells","volume":"44","author":"Hofmann","year":"2003","journal-title":"J Nuc Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib62","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1007\/s00259-003-1261-7","article-title":"99mTc-bombesin detects prostate cancer and invasion of pelvic lymph nodes","volume":"30","author":"Scopinaro","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00259-002-1040-x","article-title":"[99mTc]demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging","volume":"30","author":"Nock","year":"2003","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib64","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00259-004-1476-2","article-title":"High expression of peptide receptors as a novel target in gastrointestinal stromal tumours","volume":"31","author":"Reubi","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib65","first-page":"691","article-title":"GRP receptor-targeted PET of a rat pancreas carcinoma xernograft in nude mice with a 68Ga-labeled bombesin (6-14) analog","volume":"46","author":"Schuhmacher","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib66","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s002590000296","article-title":"Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma","volume":"27","author":"Kwekkeboom","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib67","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/snuc.2002.31028","article-title":"Cholecystokinin-B\/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor expressing malignancies","volume":"32","author":"Behr","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib68","first-page":"281","article-title":"Preclinical evaluation of minigastrin analogs for CCK-B receptor targeting","volume":"18","author":"Bernard","year":"2003","journal-title":"Cancer Biother Radiopharm"},{"issue":"suppl","key":"10.1053\/j.semnuclmed.2006.03.007_bib69","first-page":"92P","article-title":"Indium-111 labeled GLP-1 for in vivo diagnostic of insulinomas","volume":"43","author":"B\u00e9h\u00e9","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib70","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00259-002-0761-1","article-title":"Use of the incretin hormone glucagon-like peptide-I (GLP-I) for the detection of insulinomas","volume":"29","author":"Gotthardt","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib71","first-page":"4636","article-title":"Y1-mediated effect of neuropeptide Y in cancer","volume":"61","author":"Reubi","year":"2001","journal-title":"Cancere Res"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib72","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1158\/1078-0432.CCR-04-0821","article-title":"High expression of neuropeptide Y receptors in tumors of the human adrenal gland and extraadrenal paraganglia","volume":"10","author":"K\u00f6rner","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib73","first-page":"1649","article-title":"Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients","volume":"44","author":"Buchegger","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib74","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/BF01254476","article-title":"Visualization of the thymus by substance P receptor scintigraphy in man","volume":"23","author":"van Hagen","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib75","article-title":"Diffusible brachytherapy (DBT) with radiolabeled substance P in high grade gliomas","volume":"28","author":"Schumacher","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib76","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s002590000325","article-title":"Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumors","volume":"27","author":"Hessenius","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib77","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s002590100626","article-title":"FDG-PET for clinical use. Results of the 3rd German interdisciplinary consensus conference \u201cOnko-PET III\u201d, 21 July and 19 September 2000","volume":"28","author":"Reske","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib78","doi-asserted-by":"crossref","first-page":"BP115","DOI":"10.1007\/s00259-003-1355-2","article-title":"FDG-PET","volume":"30","author":"Bombardieri","year":"2003","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002590050197","article-title":"Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours","volume":"25","author":"Adams","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib80","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s002689900439","article-title":"Neuroendocrine tumors imaging","volume":"22","author":"Pasquali","year":"1998","journal-title":"World J Surg"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib81","first-page":"68","article-title":"Use of PET in neuroendrocrine tumors. In vivo applications and in vitro studies","volume":"44","author":"Eriksson","year":"2000","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.2002.tb04422.x","article-title":"The role of PET in localization of neuroendocrine and adrenocortical tumors","volume":"970","author":"Eriksson","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib83","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.82.2.457","article-title":"Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography","volume":"82","author":"Schwaiger","year":"1990","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib84","first-page":"1125","article-title":"PET scanning with hydroxyephedrine","volume":"33","author":"Shulkin","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib85","first-page":"1287","article-title":"Myocardial kinetics of 11C-metahydroxyephedrine","volume":"34","author":"De Grado","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib86","first-page":"16","article-title":"PET hydroxyephedrine imaging of neuroblastoma","volume":"37","author":"Shulkin","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0163-7258(01)00144-9","article-title":"The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines","volume":"91","author":"Eisenhofer","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib88","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.mnm.0000189780.54658.e8","article-title":"Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [123I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites","volume":"27","author":"Mamede","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib89","first-page":"3641","article-title":"A \u201cpheo\u201d lurks","volume":"86","author":"Pacak","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib90","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1210\/jc.2003-030235","article-title":"Superiority of 6-[18F]-Fluorodopamine positron emission tomography versus [131I]-Metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma","volume":"88","author":"Ilias","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib91","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0038-1632205","article-title":"Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography","volume":"38","author":"Hoegerle","year":"1999","journal-title":"Nuklearmedizin"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib92","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.195.2.7724749","article-title":"Pancreatic neuroendocrine tumors","volume":"195","author":"Ahlstrom","year":"1995","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib93","first-page":"32","article-title":"In vivo demonstration of enzyme activity in endocrine pancreatic tumors","volume":"37","author":"Bergstrom","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib94","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002590000404","article-title":"18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels","volume":"28","author":"Hoegerle","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib95","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2222010622","article-title":"Pheochromocytomas","volume":"222","author":"Hoegerle","year":"2003","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib96","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.1998.16.7.2534","article-title":"Positron emission tomography with 5-hydroxytryptophan in neuroendocrine tumors","volume":"16","author":"Orlefors","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib97","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0969-8051(99)00085-2","article-title":"Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoids tumors by specific positioning labelling in positron emission tomography","volume":"27","author":"Sundin","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib98","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1210\/jc.2004-1938","article-title":"Whole-body 11C-5-Hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors","volume":"90","author":"Orlefors","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2006.03.007_bib99","first-page":"172S","article-title":"68(Ga)-labeled peptides in tumor imaging","volume":"46","author":"Maecke","year":"2005","journal-title":"J Nucl Med"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2006.03.007_bib100","first-page":"C-0409","article-title":"Receptor-PET\/CT of neuroendocrine tumors using the gallium-68 labelled somatostatin analog DOTA-NOC","volume":"15","author":"Baum","year":"2005","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib101","first-page":"1053","article-title":"PET imaging of somatostatin receptors using [68Ga]DOTA-D-Phe1-Tyr3-Octreotide","volume":"42","author":"Henze","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib102","first-page":"213","article-title":"64Cu-TETA-Octreotide as a PET imaging agent for patients with neuroendocrine tumors","volume":"42","author":"Anderson","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib103","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00259-002-1012-1","article-title":"PET imaging of somatostatin receptors","volume":"30","author":"Wester","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib104","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib105","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0090-4295(01)00966-9","volume":"57","author":"Klingler","year":"2001","journal-title":"Pheochromocytoma. Urology"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib106","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-134-4-200102200-00016","article-title":"Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma","volume":"134","author":"Pacak","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib107","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2265.1998.3751208.x","article-title":"Differences between sporadic and multiple endocrine neoplasia type 2A pheochromocytoma","volume":"48","author":"Pomares","year":"1998","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib108","first-page":"576","article-title":"131-Iodine-metaiodobenzylguanidine for the locating of suspected pheochromocytoma","volume":"26","author":"Shapiro","year":"1985","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib109","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00842788","article-title":"The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG)","volume":"16","author":"Troncone","year":"1990","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib110","first-page":"217","article-title":"Nuclear medicine imaging of pheochromocytoma and neuroblastoma","volume":"43","author":"Sisson","year":"1999","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib111","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1043-2760(01)00492-1","article-title":"Radioisotope diagnosis and therapy of malignant pheochromocytoma","volume":"12","author":"Shapiro","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib112","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2265.2004.02077.x","article-title":"Does iodine-131-meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial pheochromocytoma?","volume":"61","author":"Taieb","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib113","first-page":"173","article-title":"Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and post-operative evaluation of paragangliomas","volume":"34","author":"Maurea","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib114","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/110241598750004913","article-title":"Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas","volume":"164","author":"Jalil","year":"1998","journal-title":"Eur J Surg"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2796.2001.00792.x","article-title":"Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of pheochromocytomas","volume":"249","author":"Berglund","year":"2001","journal-title":"J Intern Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib116","first-page":"993","article-title":"Chromogranin A assay and 131I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma","volume":"42","author":"d\u2019Herbomez","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib117","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.sla.0000193833.51108.24","article-title":"Detecting pheochromocytoma","volume":"243","author":"Guller","year":"2006","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib118","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1442-2042.1999.06310.x","article-title":"Diagnosis of pheochromocytoma using [123I]- compared with [131I]-metaiodobenzylguanidine scintigraphy","volume":"6","author":"Furuta","year":"1999","journal-title":"Int J Urol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib119","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/1097-0142(20010715)92:2<263::AID-CNCR1318>3.0.CO;2-Z","article-title":"Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma","volume":"92","author":"Adams","year":"2001","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib120","series-title":"Radioguided Surgery","article-title":"Radioguided Surgery of Neuroendocrine tumors","author":"Baum","year":"2006"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib121","first-page":"685","article-title":"[123I]Metaiodobenzylguanidine and [111In]Octreotide uptake in benign and malignant pheochromocytomas","volume":"86","author":"van der Harst","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib122","first-page":"344","article-title":"Nuclear medicine therapy of pheochromocytoma and neuroblastoma","volume":"43","author":"Troncone","year":"1999","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib123","first-page":"873","article-title":"Octreotide scintigraphy for detection of paragangliomas","volume":"34","author":"Kwekkeboom","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib124","first-page":"620","article-title":"Dopamine-producing paraganglioma not visualized by iodine-123-MIBG scintigraphy","volume":"36","author":"van Gelder","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib125","first-page":"1795","article-title":"18F-FDG-PET in characterizing adrenal lesions detected on CT or MRI","volume":"42","author":"Yun","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib126","first-page":"185","article-title":"Clinical role of positron emission tomography (PET) in endocrine tumours","volume":"44","author":"Rubello","year":"2002","journal-title":"Panminerva Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib127","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiology.212.1.r99jl3035","article-title":"Pheochromocytomas","volume":"212","author":"Shulkin","year":"1999","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib128","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/s-2005-921091","article-title":"Diagnosis and management of tumors of the adrenal medulla","volume":"37","author":"Ilias","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib129","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.HYP.38.1.6","article-title":"6-[18F]-fluorodopamine positron emission tomography (PET) scanning for diagnostic localization of pheochromocytoma","volume":"38","author":"Pacak","year":"2001","journal-title":"Hypertension"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10689-004-2155-y","article-title":"Imaging of pheochromocytoma and paraganglioma","volume":"4","author":"Brink","year":"2005","journal-title":"Familial Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib131","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1210\/jc.2003-031234","article-title":"In search of pheochromocytomas","volume":"88","author":"Mangner","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib132","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1740-8261.2002.tb01667.x","article-title":"Imaging of pheochromocytoma in 2 dogs using p-[18F]fluorobenzylguanidine","volume":"43","author":"Berry","year":"2002","journal-title":"Vet Radiol Ultrasound"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib133","first-page":"31","article-title":"Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy","volume":"47","author":"Boubaker","year":"2003","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib134","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1200\/JCO.2004.07.144","article-title":"Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma","volume":"22","author":"Katzenstein","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib135","doi-asserted-by":"crossref","first-page":"BP45","DOI":"10.1007\/s00259-003-1138-9","article-title":"Guidelines for radioiodinated MIBG scintigraphy in children","volume":"30","author":"Olivier","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib136","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/1096-911X(20001201)35:6<688::AID-MPO44>3.0.CO;2-7","article-title":"Combined 111In-Pentetreotide scintigraphy and 123I-mIBG scintigraphy in neuroblastoma provides prognostic information","volume":"35","author":"Schilling","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib137","first-page":"1172","article-title":"Neuroblastoma","volume":"45","author":"Kushner","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib138","first-page":"2385","article-title":"Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors","volume":"3","author":"Briganti","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib139","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1200\/JCO.2001.19.14.3397","article-title":"Extending positron emission tomography scan utility to high-risk neuroblastoma","volume":"19","author":"Kushner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib140","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/oxfordjournals.annonc.a010633","article-title":"Neuroendocrine gastrointestinal tumors","volume":"7","author":"Oberg","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib141","first-page":"3","article-title":"State of the art and future prospects in the management of neuroendocrine tumors","volume":"44","author":"Oberg","year":"2000","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib142","first-page":"13","article-title":"Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract","volume":"44","author":"Rindi","year":"2000","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib143","first-page":"22","article-title":"Laboratory tests for neuroendocrine tumours","volume":"44","author":"Seregni","year":"2000","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib144","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(98)02286-7","article-title":"Carcinoid tumor","volume":"352","author":"Caplin","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib145","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/archsurg.136.9.1020","article-title":"Intraoperative ultrasound and preoperative localization detects all occult insulinomas","volume":"136","author":"Hiramoto","year":"2001","journal-title":"Arch Surg"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib146","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/cncr.10614","article-title":"Endoscopic ultrasound-guided fine-needle aspiration in 179 cases","volume":"96","author":"Shin","year":"2002","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib147","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","article-title":"Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide","volume":"20","author":"Krenning","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib148","first-page":"359","article-title":"Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors","volume":"44","author":"Schillaci","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib149","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00001622-200007000-00015","article-title":"Carcinoid and pancreatic endocrine tumors","volume":"12","author":"Jensen","year":"2000","journal-title":"Curr Opin Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib150","first-page":"1155","article-title":"Intraoperative gamma probe detection of neuroendocrine tumors","volume":"39","author":"Adams","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib151","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s002590100600","article-title":"Intraoperative tumor detection using 111In-DTPA-D-Phe1-octreotide and a scintillator detector","volume":"28","author":"Benjegard","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib152","first-page":"853","article-title":"Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors","volume":"38","author":"Lebtahi","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib153","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s002590050314","article-title":"Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumors","volume":"25","author":"Chiti","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib154","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00006231-200405000-00004","article-title":"Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours","volume":"25","author":"Savelli","year":"2004","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/gast.1997.v112.pm9024287","article-title":"Value of somatostatin receptor scintigraphy","volume":"112","author":"Termanini","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib156","first-page":"150","article-title":"Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors","volume":"48","author":"Bombardieri","year":"2004","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib157","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00259-005-1760-9","article-title":"Hybrid SPET\/CT","volume":"32","author":"Schillaci","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib158","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2265.2003.01885.x","article-title":"SPECT\/CT hybrid imaging with 111In-pentetreotide in assessmentt of neuroendocrine tumours","volume":"59","author":"Krausz","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib159","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1378\/chest.117.5.1232","article-title":"A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules","volume":"117","author":"Blum","year":"2000","journal-title":"Chest"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib160","first-page":"889","article-title":"Detection of neuroendocrine tumors","volume":"43","author":"Lebtahi","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib161","first-page":"S100","article-title":"Somatostatin receptor scintigraphy using Tc-99m EDDA-TRYCINE-HYNIC-TOC","volume":"29","author":"Baum","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib162","first-page":"237","article-title":"99mTc-EDDA\/HYNIC-Tyr(3)-octreotide for staging and follow-up of patients with neuroendocrine gastro-entero-pancreatic tumors","volume":"49","author":"Gabriel","year":"2005","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib163","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/0959-8049(96)00241-9","article-title":"Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours","volume":"32A","author":"Taal","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib164","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1210\/jcem.86.2.7194","article-title":"Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors","volume":"86","author":"Kaltsas","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib165","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/BF01254466","article-title":"Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours","volume":"23","author":"Nocaudie-Calzada","year":"1996","journal-title":"Eur J Nucl Med"},{"issue":"suppl 1 to no. 4","key":"10.1053\/j.semnuclmed.2006.03.007_bib166","first-page":"140","article-title":"Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor","volume":"39","author":"Rufini","year":"1995","journal-title":"Q J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib167","first-page":"1121","article-title":"A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and a iodine-labeled somatostatin analog (tyr-3-octreotide) in metastatic carcinoid tumors","volume":"33","author":"Bomanji","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib168","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF01731835","article-title":"Successful and unsuccessful approaches to imaging carcinoids","volume":"23","author":"Macfarlane","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib169","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/qjmed\/89.7.539","article-title":"Imaging secondary neuroendocrine tumours of the liver","volume":"89","author":"Ramage","year":"1996","journal-title":"QJM"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib170","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1210\/jcem.87.4.8407","article-title":"Ocular metastases secondary to carcinoid tumors","volume":"87","author":"Isidori","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib171","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00006231-199807000-00005","article-title":"Metabolic (PET) and receptor (SPET) imaging of well-and less well-differentiated tumours","volume":"19","author":"Adams","year":"1998","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib172","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/02841869309083911","article-title":"Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors","volume":"32","author":"Eriksson","year":"1993","journal-title":"Acta Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib173","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiology.220.2.r01au25373","article-title":"Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors","volume":"220","author":"Hoegerle","year":"2001","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib174","first-page":"1161","article-title":"Imaging of advanced neuroendocrine tumours with 18F-DOPA PET","volume":"45","author":"Becherer","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib175","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1536-1632(03)00038-6","article-title":"Evaluation of positron emission tomography imaging using [68Ga]-Dota-D-Phe(I)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors","volume":"5","author":"Kowalski","year":"2003","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib176","first-page":"S53","article-title":"Clinical application of Ga-68-DOTATOC in 132 patients with neuroendocrine tumors","volume":"32","author":"Hofmann","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib177","first-page":"S109","article-title":"Imaging of somatostatin-receptor expressing neuroendocrine tumours with 68Ga-DOTATOC-PET\/CT versus 111In-DTPA-octreotide SPECT\/CT","volume":"32","author":"\u00d6ks\u00fcz","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib178","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic ACTH syndrome","volume":"91","author":"Isidori","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib179","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing\u2019s syndrome due to ectopic corticotropin secretion","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib180","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1210\/jcem.84.4.5583","article-title":"Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome","volume":"84","author":"Tabarin","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib181","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/jc.2003-031812","article-title":"The role of [18F]fluorodeoxyglucose positron emission tomography and [111In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing\u2019s syndrome","volume":"89","author":"Pacak","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib182","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2265.2001.01150-4.x","article-title":"Reply: Ectopic ACTH syndrome: a diagnostic challenge!","volume":"54","author":"Roelants","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib183","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2265.2003.01853.x","article-title":"PET scan in occult ectopic ACTH syndrome a useful tool?","volume":"59","author":"Biering","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib184","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ssu.2980070209","article-title":"Medullary carcinoma of the thyroid","volume":"7","author":"Lairmore","year":"1991","journal-title":"Semin Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/erc.0.0080135","article-title":"Treatment of medullary thyroid carcinoma","volume":"8","author":"Orlandi","year":"2001","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib186","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/bjc.1994.224","article-title":"Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma","volume":"69","author":"Abdelmoumene","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib187","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","article-title":"Medullary thyroid carcinoma","volume":"88","author":"Kebebew","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib188","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejso.2004.06.011","article-title":"Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients","volume":"31","author":"Szavcsur","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib189","first-page":"3190s","article-title":"Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine-131-labeled bivalent hapten","volume":"5","author":"Kraeber-Bodere","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib190","first-page":"273","article-title":"Role of nuclear medicine in the diagnosis and therapy of medullary thyroid carcinoma","volume":"25","author":"Rufini","year":"2000","journal-title":"Rays"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib191","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/108497804773391694","article-title":"Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas","volume":"19","author":"Bodei","year":"2004","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib192","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/1097-0142(19871101)60:9<2189::AID-CNCR2820600913>3.0.CO;2-C","article-title":"Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study","volume":"60","author":"Baulieu","year":"1987","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib193","first-page":"33","article-title":"Pentavalent 99m-Tc-DMSA, 131-I-MIBG, and 99m-Tc-MDP. An evaluation of three imaging techniques with medullary carcinoma of the thyroid","volume":"29","author":"Clarke","year":"1988","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib194","first-page":"912","article-title":"Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma","volume":"37","author":"Baudin","year":"1996","journal-title":"J Nucl Med"},{"issue":"suppl 13","key":"10.1053\/j.semnuclmed.2006.03.007_bib195","first-page":"42","article-title":"The contribution of somatostatin receptor scintigraphy and conventional imaging in medullary thyroid carcinoma","volume":"21","author":"D\u00f6rr","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib196","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2436::AID-CNCR16>3.0.CO;2-D","article-title":"Anticarcynoembrionic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma","volume":"80","author":"Behr","year":"1997","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib197","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2265.2001.01175.x","article-title":"Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid","volume":"54","author":"Papotti","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib198","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00432-004-0588-1","article-title":"The role of combined imaging in metastatic medullary thyroid carcinoma","volume":"130","author":"Gao","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib199","first-page":"567","article-title":"Somatostatin receptors and somatostatin content in medullary thyroid carcinomas","volume":"64","author":"Reubi","year":"1991","journal-title":"Lab Invest"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib200","first-page":"70","article-title":"Metabolic and receptor imaging of metastatic medullary thyroid cancer","volume":"26","author":"Behr","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib201","first-page":"1172","article-title":"Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA \u00d7 anti-DTPA-indium bispecific antibody","volume":"39","author":"Barbet","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib202","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/BF01254467","article-title":"In vivo imaging of chromogranin A positive endocrine tumors by three-step monoclonal antibody targeting","volume":"23","author":"Siccardi","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/108497804323071995","article-title":"99mTc-EDDA\/HYNIC-TOC in the management of medullary thyroid carcinoma","volume":"19","author":"Parisella","year":"2004","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib204","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s002590100614","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer","volume":"28","author":"Diehl","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib205","first-page":"66","article-title":"18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma","volume":"43","author":"Szakall","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib206","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1245\/ASO.2004.10.015","article-title":"Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer","volume":"11","author":"De Groot","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib207","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/107327480501200408","article-title":"Review of fluorine-18-2-fluoro-2deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas","volume":"12","author":"Khan","year":"2005","journal-title":"Cancer Control"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib208","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s002590050533","article-title":"The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer","volume":"27","author":"Brandt-Mainz","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2006.03.007_bib209","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00006231-200405000-00003","article-title":"18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma","volume":"25","author":"Gotthardt","year":"2004","journal-title":"Nucl Med Commun"},{"issue":"suppl 2","key":"10.1053\/j.semnuclmed.2006.03.007_bib210","first-page":"201P","article-title":"Ga-68- DOTA-1-Nal3-Octreotide (DOTA-NOC) receptor PET\/CT imaging for the diagnosis of neuroendocrine tumors and follow-up after peptide receptor radiotherapy","volume":"45","author":"Baum","year":"2005","journal-title":"J Nucl Med"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299806000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299806000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T17:24:59Z","timestamp":1683480299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299806000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":210,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0001299806000183"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2006.03.007","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}